CASE STUDY
Value & Access Organization Design
Building the right Value & Access structure for an innovative, clinical-stage biotech
Situation
The newly-appointed Global Head of Value & Access at an exciting clinical-stage biotech needed to design her organization, at the same time as leading value & access strategy for multiple products in late development, in rare and high-prevalence indications – including the company’s first ever launch.
Action
AESARA Strategy Consultants who have led as well as designed global and regional Value & Access (V&A) groups
- Quickly established familiarity with the client biotech’s strategy and culture, through interviews with cross-functional executives
- Tailored our deep industry experience into a benchmarking report
- Selected comparator and contrastor company V&A org structures
- Identified practical lessons specific to the client’s strategy, portfolio and maturity
- Identified practical lessons specific to the client’s strategy, portfolio and maturity
- Designed and iterated vison, mission, structure and resourcing, in close collaboration with client executive
IMPACT
- Delivered a bespoke and future-fit Value, Access & Policy organization
- Focused on first-launch success
- Scalable in line with company investment trajectory and inflection points
- Innovatively designed and presented “market-inwards”, not routine “top-down”
- Through sequential and careful touchpoints, used creative communications to bring C-suite executives on the journey, to approve the ultimate design and resource ask
